Acta OphthalmologicaPub Date : 2026-12-01Epub Date: 2026-06-22DOI: 10.1111/aos.70174
Evripidis Sykakis, Anastasia Tsiogka, Vasileios Selimis, Minas I Aslanides, Athanasios Skouras, George Kenanakis, Ioannis M Aslanides, Minas M Stylianakis
{"title":"A prospective randomised comparison of two different stenting sutures when using the Baerveldt 101-350 aqueous shunt - Lab transition to clinical process.","authors":"Evripidis Sykakis, Anastasia Tsiogka, Vasileios Selimis, Minas I Aslanides, Athanasios Skouras, George Kenanakis, Ioannis M Aslanides, Minas M Stylianakis","doi":"10.1111/aos.70174","DOIUrl":"10.1111/aos.70174","url":null,"abstract":"<p><strong>Purpose: </strong>The Baerveldt glaucoma drainage implant (BGI 101-350) is one of the most effective treatment options for managing refractory glaucoma. To mitigate early hypotony in non-valved implants, intraluminal occluding sutures (IOSs) are commonly used. This study compares the swelling behavior of two widely used IOSs: 3-0 nylon (Supramid Extra) and 3-0 polypropylene (Prolene). Long-term clinical outcomes associated with each suture material are also evaluated.</p><p><strong>Methods: </strong>A prospective randomised interventional study was conducted involving 94 patients undergoing BGI 101-350 implantation, divided into two groups: Supramid (n = 48) and Prolene (n = 46). An experimental swelling model using confocal microscopy and ImageJ software quantified the hygroscopic behavior of each suture material by determining the intraluminal gaps area before and after wetting. Postoperative intraocular pressure (IOP), medication use and removal timing were analyzed over 60 months using independent-samples t-tests, while categorical variables, including hypotony rates and the need for suture adjustment, were compared using χ<sup>2</sup> tests.</p><p><strong>Results: </strong>The experimental model demonstrated ~60% swelling in Supramid vs. ~3% in Prolene IOS. Clinically, both groups achieved comparable IOP control at 6, 12 and 60 months (mean IOP at 60 months: Supramid 11 ± 1.75 mmHg, Prolene 11 ± 1.37 mmHg; p > 0.05). The Prolene group required markedly fewer postoperative interventions: no suture adjustments compared with 10 in the Supramid group (p = 0.001), and suture removal occurred significantly later (mean 8.9 vs. 4.96 months; p < 0.001). Transient hypotony following suture removal occurred in 6.25% of Supramid cases and in none with Prolene.</p><p><strong>Conclusions: </strong>3-0 Prolene offers better predictability and repeatability, earlier IOP control, delayed and safer suture removal and reduced need for early interventions while maintaining equivalent long-term IOP control.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e950-e959"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148300673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta OphthalmologicaPub Date : 2026-12-01Epub Date: 2026-07-28DOI: 10.1111/aos.70197
Ajda Kunčič, Nataša Debeljak, Petra Hudler, Janez Smerkolj, Mojca Urbančič
{"title":"Macular telangiectasia type 2 genetic risk variants associated with clinical characteristics in the Slovenian cohort.","authors":"Ajda Kunčič, Nataša Debeljak, Petra Hudler, Janez Smerkolj, Mojca Urbančič","doi":"10.1111/aos.70197","DOIUrl":"10.1111/aos.70197","url":null,"abstract":"<p><strong>Purpose: </strong>Early diagnosis of macular telangiectasia type 2 (MacTel) remains challenging, and the contribution of genetic variation to its clinical heterogeneity is unclear. This study investigated associations between MacTel risk variants and clinical characteristics in a Slovenian cohort.</p><p><strong>Methods: </strong>In this case-control study, including 65 patients with MacTel and 73 healthy controls, participants underwent a complete ophthalmological examination and multimodal imaging. Clinical parameters included best-corrected visual acuity (BCVA), retinal thickness, area of ellipsoid zone (EZ) break, retinal pigment epithelium (RPE) hyperplasia and neovascularization (NV). Ten MacTel risk variants were genotyped using TaqMan assays. A polygenic risk score (PRS) was calculated, and phenotype-phenotype and genotype-phenotype associations were evaluated using correlation and regression analyses.</p><p><strong>Results: </strong>Visual acuity declined with progressive retinal changes, including a larger area of EZ break (ρ = 0.72), RPE hyperplasia (ρ = 0.49) and NV (ρ = 0.55; all p<sub>adj</sub> < 0.05). Two variants showed nominal differences in minor allele frequency between groups: rs36259 (CERS4) and rs146953046 (PHGDH), with the latter associated with higher odds of MacTel (OR = 3.51, p = 0.040). The rs11077850-C allele (SNHG16) showed nominal associations with better BCVA (logMAR) (ρ = -0.33, p = 0.0066), a smaller area of EZ break (ρ = -0.27, p = 0.032) and lower odds of progressed disease (OR = 0.30, p = 0.011). These associations were attenuated after FDR correction. A PRS constructed from five MacTel risk variants, combined with age moderately discriminated patients from controls (AUC = 0.68).</p><p><strong>Conclusion: </strong>MacTel risk variants are associated with clinically relevant functional and structural retinal changes. Integrating genetic information with multimodal imaging may support risk stratification and earlier recognition in selected patients.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e982-e992"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148597388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta OphthalmologicaPub Date : 2026-12-01Epub Date: 2026-06-28DOI: 10.1111/aos.70178
Rachael C Heath Jeffery, Bohdan Kousal, Ulrike Grünert, Christine A Curcio, Svetlana Cherepanoff, Tina M Lamey, Michel Michaelides, Chrysanthi Tsika, Isabelle Chow, Omar A Mahroo, Seungmin Lee, Martin Meliska, Milos Kubanek, Jakub Sikora, Siying Lin, Raymond C B Wong, Petra Liskova, Fred K Chen
{"title":"Radial outer retina reflectivity (RORR) sign in LAMP2-associated retinopathy.","authors":"Rachael C Heath Jeffery, Bohdan Kousal, Ulrike Grünert, Christine A Curcio, Svetlana Cherepanoff, Tina M Lamey, Michel Michaelides, Chrysanthi Tsika, Isabelle Chow, Omar A Mahroo, Seungmin Lee, Martin Meliska, Milos Kubanek, Jakub Sikora, Siying Lin, Raymond C B Wong, Petra Liskova, Fred K Chen","doi":"10.1111/aos.70178","DOIUrl":"10.1111/aos.70178","url":null,"abstract":"<p><strong>Purpose: </strong>To describe the radial outer retina reflectivity (RORR) sign in patients carrying pathogenic variants in the X-linked lysosome-associated membrane protein-2 (LAMP2) gene and to review the histologic characteristics of LAMP2 expression in the human retina.</p><p><strong>Methods: </strong>International multicentre observational case series and experimental laboratory study of patients with LAMP2 deficiency. Baseline demographics and multimodal retinal imaging including colour and fundus autofluorescence (FAF), optical coherence tomography (OCT) with en face reconstruction and fluorescein angiography were obtained. Sections through the retina of a human donor eye were processed for immunofluorescence combining antibodies against LAMP2 with markers for Müller glia, rod and cone photoreceptors. Sections were imaged using high-resolution multichannel confocal microscopy. Assessment of en face OCT reflectivity profiles at 5-50 μm internal to the plane of external limiting membrane (ELM) was performed as well as histologic localisation of LAMP2.</p><p><strong>Results: </strong>We recruited 11 cases with pathogenic variants in LAMP2 across five countries. Six cases demonstrated peripheral radial streaks of hyper- and hypopigmentation with UWF imaging. The RORR sign was best visualised 10-25 μm internal to ELM in 9 cases. We hypothesise the radial pattern to be secondary to X-chromosome inactivation. LAMP2 immunoreactivity was observed internal and external to the ELM.</p><p><strong>Conclusion: </strong>Our findings expand the phenotypic spectrum of LAMP2-associated retinopathy by demonstrating the RORR sign using en face OCT. Histologic sections revealed LAMP2 expression in the neuroretina.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e960-e972"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148343781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta OphthalmologicaPub Date : 2026-12-01Epub Date: 2026-05-25DOI: 10.1111/aos.70159
Anne-Sofie Petri, Sindri Traustason, Sveinn H Hardarson, Alexander Kyhnel, Einar Stefansson, Jens F Kiilgaard, Morten la Cour, Javad Nouri Hajari, Therese Krarup
{"title":"The effect of rhegmatogenous retinal detachment on retinal oxygenation.","authors":"Anne-Sofie Petri, Sindri Traustason, Sveinn H Hardarson, Alexander Kyhnel, Einar Stefansson, Jens F Kiilgaard, Morten la Cour, Javad Nouri Hajari, Therese Krarup","doi":"10.1111/aos.70159","DOIUrl":"10.1111/aos.70159","url":null,"abstract":"<p><strong>Purpose: </strong>Little is known about the effects of retinal detachment on oxygen extraction from retinal vessels. The role of oxygen supply from the retinal vessels in a detached area has not previously been investigated in vivo in humans. Retinal oximetry is a non-invasive measurement of retinal oxygen saturation. The aim of this study was to investigate the alteration of the arterio-venous oxygen saturation in the retina during a rhegmatogenous retinal detachment using oximetry.</p><p><strong>Methods: </strong>The study was a prospective observational study on patients with recent onset partial rhegmatogenous retinal detachment in 149 patients during the period May 2010 to December 2012. Oxygen saturation was measured in retinal vessels located in an area of attached retina but supplying an area of detached retina.</p><p><strong>Results: </strong>Retinal detachment resulted in significantly decreased retinal arterial oxygen saturation, increased retinal venous saturation and a decrease in arterio-venous saturation difference (Figure 2, p = 0.037, p = 0.031 and p = 0.00024, respectively, paired t-test), when compared to matched attached area in the fellow eye. In the detached retinal areas, there was a significant increase in retinal venous saturation and a decrease in arterio-venous saturation difference (Figure 3, p = 0.0019 and p = 0.044, respectively, paired t-test), when compared to attached retina in the same eye.</p><p><strong>Conclusion: </strong>Our results demonstrated a significant decrease in arterio-venous saturation in detached retina. This could indicate that the retina has an ability to downregulate the metabolic activity thereby minimizing cell death and deterioration of the retinal layers or it might indicate cell death and decreased oxygen consumption.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e993-e1000"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148013067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta OphthalmologicaPub Date : 2026-12-01Epub Date: 2026-05-16DOI: 10.1111/aos.70161
Miklos Schneider, Leyla Turan, Farah Arif, Jakob Bjerager, Oliver Niels Klefter, Carsten Faber, Yousif Subhi, Javad Nouri Hajari
{"title":"Real-world incidence and clinical characteristics of intraocular inflammation following intravitreal faricimab therapy: A safety study.","authors":"Miklos Schneider, Leyla Turan, Farah Arif, Jakob Bjerager, Oliver Niels Klefter, Carsten Faber, Yousif Subhi, Javad Nouri Hajari","doi":"10.1111/aos.70161","DOIUrl":"10.1111/aos.70161","url":null,"abstract":"<p><strong>Purpose: </strong>To estimate the real-world incidence of intraocular inflammation (IOI) following intravitreal faricimab injections at a large, highly specialized tertiary centre.</p><p><strong>Methods: </strong>Single-centre, retrospective cohort study with chart review using an electronic injection database and electronic medical records from November 2023 to August 2024.</p><p><strong>Results: </strong>The study included 6054 patients, 7510 eyes and 31 393 injections. During the inclusion period, 42 eyes of 40 patients developed IOI, resulting in 48 IOI events. The incidence of IOI was 0.66% per patient, 0.56% per eye and 0.13% per injection. IOI occurred after a median of 4 faricimab injections (IQR: 2, range: 1-9) and a median of 8.5 days (IQR: 20, range: 0-37) after the last injection. The median disease duration (time from diagnosis to resolution) was 32 days (IQR: 46, range: 6-144). Eighty per cent of patients who developed IOI were females, and females had 2.42-2.66 times higher hazard of developing IOI than males. Most IOI cases were anterior or anterior + intermediate uveitis (47.9% and 33.3%, respectively). All panuveitis cases (n = 6) underwent vitrectomy, and one had a positive culture, yielding a 0.003% per-injection incidence of culture-positive endophthalmitis. Cases rechallenged with faricimab following IOI (n = 13) had a relapse in 46.15%. The change in median best-corrected visual acuity between before and after IOI events was not statistically significant.</p><p><strong>Conclusions: </strong>Faricimab demonstrated an acceptable safety profile in our study. The incidence of IOI events was consistent with those observed in other real-world reports. The IOI events showed a female predominance, varied presentations and durations, but generally had favourable outcomes.</p><p><strong>Study registration: </strong>ClinicalTrials.gov registration number: NCT06902207, Date of registration: 15/03/2025 retrospectively registered.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e1008-e1017"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751878/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147947475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta OphthalmologicaPub Date : 2026-12-01Epub Date: 2026-05-27DOI: 10.1111/aos.70164
Ebrahimi Seyed-Mohsen, Väyrynen Tommi, Huotari Niko, Saarela Ville, Honkamo Marja, Helakari Heta, Järvelä Matti, Korhonen Vesa, Raitamaa Lauri, Kiviniemi Vesa
{"title":"Phase coupling between eye and brain pulsations is bidirectional and modulated by the parasympathetic system - An fMREye study.","authors":"Ebrahimi Seyed-Mohsen, Väyrynen Tommi, Huotari Niko, Saarela Ville, Honkamo Marja, Helakari Heta, Järvelä Matti, Korhonen Vesa, Raitamaa Lauri, Kiviniemi Vesa","doi":"10.1111/aos.70164","DOIUrl":"10.1111/aos.70164","url":null,"abstract":"<p><strong>Purpose: </strong>Physiological pulsations driven by cardiac, respiratory, and vasomotor activity are essential for solute transport within perivascular and perineural cerebrospinal fluid (CSF) pathways that support brain and eye clearance systems. Previous studies have shown that parasympathetic blockade significantly reduces ocular pulsation power and induces systemic alterations in cerebral pulsations, but the connecting mechanism has been uncertain.</p><p><strong>Methods: </strong>We first investigated classical cross-correlation (CC) strength and lag values between brain and eye regions of interest (ROIs) and then examined the phase-based relationship between their physiological pulsations. We further assessed how this relationship is affected by topical parasympathetic blockade using tropicamide. Functional magnetic resonance eye imaging (fMREye) data were analysed from 46 healthy volunteers, with and without topical tropicamide. Static correlation analysis and dynamic phase transfer entropy (dPTE) served to quantify directional interactions across three physiological frequency bands: very-low-frequency (VLF), respiratory (RESP), and cardiac (CARD).</p><p><strong>Results: </strong>At baseline, CC analysis revealed the strongest correlations in the CARD and RESP bands, particularly between peri-optic CSF and interpeduncular cisterns. With tropicamide, CC values were significantly higher in most connections. VLF correlations were weaker and remained mostly unchanged. Constant lag analysis revealed unphysiologically long lags. However, the deeper dynamic phase analysis revealed previously unforeseen low-frequency oscillations in the phases between the pulsations. The directional dPTE showed a near-zero net information transfer and a faint predilection for CARD pulsation directed from the eye towards the brain. Tropicamide administration significantly reduced bidirectional brain-eye information flow, with a visually greater reduction in the eye-to-brain direction. This was accompanied by significant alterations in phase dynamics, including a reversal in CARD-RESP directionality, indicating a shift in temporal precedence between frequency components, and higher CARD-VLF coupling.</p><p><strong>Conclusion: </strong>The brain-eye pulsation connections express highly dynamic bi-directionality with frequency dependent net information transfer partly modulated by (para)sympathetic activity.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e1028-e1048"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148025312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Assessment of retinal neurodegeneration in metabolic syndrome and its vascular determinants.","authors":"Ieva Simkiene, Jolita Badariene, Rimvydas Asoklis, Vilma Dzenkeviciute, Leopold Schmetterer, Jacqueline Chua","doi":"10.1111/aos.70162","DOIUrl":"10.1111/aos.70162","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate retinal nerve fibre layer (RNFL) and ganglion cell complex (GCC) thickness in individuals with and without metabolic syndrome and examine associations with vascular risk factors.</p><p><strong>Methods: </strong>In this prospective cross-sectional study, adults without ocular disease undergoing cardiovascular risk assessment were examined using spectral-domain optical coherence tomography (RTVue XR Avanti). RNFL and GCC thickness were measured. Associations between systemic factors and retinal layer thickness were analysed using linear regression with generalized estimating equations, stratified by metabolic syndrome status.</p><p><strong>Results: </strong>Among 209 participants (median age (IQR) 52 (49-56) years; 56% female), 110 (53%) had metabolic syndrome. RNFL and GCC thickness did not differ significantly by metabolic syndrome status (p > 0.05). In those with metabolic syndrome, higher mean arterial pressure (MAP; β = -0.18 μm/mmHg, p = 0.007), greater carotid intima-media thickness (β = -0.02 μm/μm, p = 0.006) and smoking (β = -4.10 μm, p = 0.040) were associated with thinner RNFL. Similarly, higher MAP (β = -0.17 μm/mmHg, p < 0.001) and smoking (β = -5.72 μm, p < 0.001) were associated with thinner GCC. In participants without metabolic syndrome, no significant associations were observed for RNFL (all p > 0.05), while thinner GCC was associated with higher BMI (β = -0.47 μm/kg/m<sup>2</sup>, p = 0.036) and higher urine albumin (β = -0.03 μm/mg/L, p < 0.001). Across all participants, smoking was associated with thinner GCC (β = -4.79 μm, p < 0.001).</p><p><strong>Conclusions: </strong>In this cardiovascular high-risk but ocular disease-free cohort, vascular factors, rather than metabolic syndrome itself, were associated with thinner RNFL and GCC. These findings suggest that vascular stress may contribute to early retinal neurodegeneration.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e1049-e1059"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147925441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta OphthalmologicaPub Date : 2026-12-01Epub Date: 2026-05-13DOI: 10.1111/aos.70168
Siar Niazi, Filip Gnesin, Baker Nawfal Jawad, Zia Niazi, Puriya Daniel Wuertz Yazdanfard, Anne P Toft-Petersen, Kathrine Kold Sørensen, Amani Meaidi, Yousif Subhi, Christian Torp-Pedersen
{"title":"Timing and duration of glucagon-like peptide-1 receptor agonist use and risk of nonarteritic anterior ischaemic optic neuropathy.","authors":"Siar Niazi, Filip Gnesin, Baker Nawfal Jawad, Zia Niazi, Puriya Daniel Wuertz Yazdanfard, Anne P Toft-Petersen, Kathrine Kold Sørensen, Amani Meaidi, Yousif Subhi, Christian Torp-Pedersen","doi":"10.1111/aos.70168","DOIUrl":"10.1111/aos.70168","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the association between glucagon-like peptide-1 receptor agonist (GLP-1RA) use and nonarteritic anterior ischaemic optic neuropathy (NAION) in type 2 diabetes, examining treatment recency and cumulative duration.</p><p><strong>Methods: </strong>This nationwide registry-based nested case-control study utilizedz Danish health registries (1996-2023). Among 201 776 metformin-treated adults initiating second-line antihyperglycaemic therapy, 123 incident NAION cases were matched to 4920 controls by birth year and sex (incidence-density sampling). Conditional logistic regression estimated adjusted hazard rate ratios (HRs) for GLP-1RA exposure by recency (current 0-90 days; recent 91-365 days) and cumulative duration, adjusting for socio-economic factors, hypertension, hypercholesterolaemia, sleep apnoea, and diabetes duration.</p><p><strong>Results: </strong>GLP-1RA use occurred in 63/123 cases (51.2%) and 1688/4920 controls (34.3%). Ever use was associated with a higher NAION rate than other second-line therapies (HR 2.13, 95% CI: 1.43-3.18). Current use was associated with elevated rates (HR 2.28, 95% CI: 1.49-3.48), whereas the estimate for recent use was imprecise (HR 1.69, 95% CI: 0.88-3.25). By cumulative duration, no clear evidence of an increase was seen within 0-½ years (HR 0.80, 95% CI: 0.32-2.05), and rates were highest at ½-1 year (HR 3.63, 95% CI: 2.06-6.40) and 1-1½ years (HR 3.52, 95% CI: 1.73-7.17). Findings were consistent after HbA1c adjustment and in a new-user analysis.</p><p><strong>Conclusion: </strong>GLP-1RA use is associated with a higher NAION rate in type 2 diabetes. This association appears time-dependent, being most pronounced during current treatment and peaking after 6-18 months of cumulative exposure.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e1018-e1027"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751875/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147925448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta OphthalmologicaPub Date : 2026-12-01Epub Date: 2026-05-18DOI: 10.1111/aos.70169
Petri Purola, Pekko Hujanen, Hannu Uusitalo, Hannele Uusitalo-Järvinen
{"title":"Impact of delayed appointments on treatment outcomes in neovascular macular degeneration.","authors":"Petri Purola, Pekko Hujanen, Hannu Uusitalo, Hannele Uusitalo-Järvinen","doi":"10.1111/aos.70169","DOIUrl":"10.1111/aos.70169","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the real-world visual outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy, the frequency of delayed appointments and the relationship between delays and visual outcomes in patients with neovascular age-related macular degeneration (nAMD).</p><p><strong>Methods: </strong>This single-centre retrospective study included a cohort of 3831 treatment-naïve nAMD patients who were treated with bevacizumab monotherapy using a pro re nata protocol between 2008 and 2023, comprising a total of 79 545 visits. Visual acuity (VA) was measured at the time of diagnosis and during follow-up visits and was converted into Early Treatment Diabetic Retinopathy Study letters. One eye per patient was included in the analysis. Delayed visits were categorised as >6 weeks and ≤8 weeks, >8 weeks and ≤ 10 weeks and >10 weeks.</p><p><strong>Results: </strong>After an initial stabilisation in VA during the first treatment year, VA started to decline. The proportion of visits delayed >6 weeks varied between 24% and 36% per treatment year, with delays being more common during the early years of the study when the new therapies were introduced. In general, the decline in VA was more severe with a higher number and longer duration of delayed visits.</p><p><strong>Conclusions: </strong>Delays in anti-VEGF injections are common and strongly associated with vision loss. Therefore, it is important to improve patient awareness and compliance. Use of new longer-acting therapies may support this process.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e1001-e1007"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147961796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta OphthalmologicaPub Date : 2026-12-01Epub Date: 2026-05-27DOI: 10.1111/aos.70160
Mary Graciya Karunainathan, Celine Lee, Kaweh Daniel Zohalinejad, Mads Odgaard Mæng, Nanna Würtz Fabrin, Sigurrós Jónsdóttir, Anne Kjærsgaard Hassing, Søren Kveiborg Yde, Charles C Wykoff, Henrik Vorum, Yousif Subhi, Marie Ørskov, Lasse Jørgensen Cehofski
{"title":"Real-world insights on switching aflibercept dosage for enhanced outcomes in age-related macular degeneration (RISE-AMD): Safety data.","authors":"Mary Graciya Karunainathan, Celine Lee, Kaweh Daniel Zohalinejad, Mads Odgaard Mæng, Nanna Würtz Fabrin, Sigurrós Jónsdóttir, Anne Kjærsgaard Hassing, Søren Kveiborg Yde, Charles C Wykoff, Henrik Vorum, Yousif Subhi, Marie Ørskov, Lasse Jørgensen Cehofski","doi":"10.1111/aos.70160","DOIUrl":"10.1111/aos.70160","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate real-world safety experience with aflibercept 8 mg in a large case series of patients with neovascular age-related macular degeneration (nAMD).</p><p><strong>Methods: </strong>Due to a high proportion of patients on short treatment intervals, patients with nAMD at a Danish tertiary retina clinic were systematically switched to aflibercept 8 mg. Safety data from May 2024 to October 2025 were obtained through a retrospective review of medical records by an experienced retina specialist and an additional reviewer. Symptomatic intraocular pressure (IOP) increase was defined as any symptom (e.g. pain) in conjunction with IOP > 21 mmHg.</p><p><strong>Results: </strong>In total, 8675 intravitreal injections of aflibercept 8 mg were administered in 1429 eyes with nAMD, including 139 glaucomatous eyes. A total of 25 AEs were reported (2.88 per 1000 injections). Intraocular inflammation (IOI) was reported in 11 eyes (1.27 per 1000 injections), with 10 eyes being managed with topical dexamethasone, while one case required vitrectomy. Symptomatic IOP increase was observed in 10 cases (1.15 per 1000 injections). The occurrence of symptomatic IOP increase did not differ between glaucomatous and non-glaucomatous eyes (p = 0.24). Two cases of bacterial endophthalmitis were registered. No case of retinal vasculitis or retinal vascular occlusion was observed.</p><p><strong>Conclusion: </strong>Incidence rates of symptomatic IOP increase and IOI were generally low. Despite a large glaucoma cohort, the higher incidence rate of symptomatic IOP increase in glaucomatous eyes did not reach statistical significance.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":"e973-e981"},"PeriodicalIF":3.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148025347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}